Business Conduct

The Group requires compliance with laws, regulations, and industry codes of conduct at all times via established policies and procedures. Its comprehensive compliance program includes a focused Integrity and Compliance department, with our Chief Integrity and Compliance Officer as a member of the Executive Committee. The Integrity and Compliance department helps assure that the Group’s operations are conducted in line with all legal and regulatory requirements, guidance from the Office of Inspector General for the U.S. Department of Health and Human Services, and the appropriate industry codes of ethics, including those published by the Pharmaceutical Research and Manufacturers of America (PhRMA); Association of the British Pharmaceutical Industry; and by Medicines Australia.

In 2018, the Group continued to enhance its Integrity and Compliance program through the implementation of the following (among other key deliverables):

 ‹ undertaking a comprehensive review of key internal processes, including implementation of appropriate enhancements;

‹ conducting ‘distributor country’ compliance training and supported multiple distributor audits;

‹ developing and disseminating an enterprise-wide quarterly Integrity and Compliance newsletter to drive awareness and best practice throughout the organization;

‹ adopting gamification as an approach to reinforce the field-based sales team’s knowledge of and compliance with policies; and

‹ appointing the Executive Committee to serve as the Indivior Compliance Committee.

Compliance Leadership

As Chief Integrity and Compliance Officer, Cindy Cetani will continue to leverage the Group’s strong commitment to compliance and its culture of integrity.  Reporting to the Chief Executive Officer, Cindy will focus on compliance program strategy, governance and sustainability, related strategic and integrated communications, workforce continuing education and development, and ongoing risk awareness and management to help assure compliance with relevant laws, regulations and industry codes of conduct.

Joining Indivior in October 2018, Cindy has more than 30 years of experience in driving a culture of learning, integrity and compliance program vision.  Cindy joined Indivior from Novartis, where she held roles of increasing responsibility over the past 15 years and was most recently Head of Compliance Operations, Group Integrity & Compliance.